22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release
here
Home
About Us
Our Company
Our Leadership Team
Board of Directors
Reduced Nicotine Tobacco
VLN®
Clinical Studies & Commentaries
Hemp/Cannabis Innovation
GVB Biopharma
Hops Research
News
Investors
Overview
New Investor / Latest Resources
Events
News
Stock Data
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
Contact Us
Annual Reports
Investors
Investors
Overview
New Investor / Latest Resources
Events
News
Press Releases
Stock Data
Quote
Charts
Historical Data
Trades
SEC Filings
Analyst Coverage
Corporate Governance
Annual Reports
FAQs
2021 Annual Report
2020 Annual Report
2019 Annual Report
2018 Annual Report
2017 Annual Report
2016 Annual Report
2015 Annual Report
2014 Annual Report
2013 Annual Report
2012 Annual Report
Email Alerts
Contact
RSS News Feed